IVR Change Management Ideas Portal
Please add new product Ojjaara to main IVR:
MI path for HCP's is for ONC skill.
Consumer path is ONC skill.
Ojjaara is trade name and Momelotinib is the generic name.
Expected Launch Readiness date coming up in May 1 with a Launch date (PDUFA) in June 16th
Email with product pronunciation sent to Eric/Stephen on 3/28/23
| Priority | Medium |
| Contact Center(s) | GRC |
| Needed By | Sep 16, 2023 |
| Closure Date | Sep 29, 2023 |
Status Notes
25-Aug-2023 - Eric - expecting approval after 5:00 today. Will implement for Monday 8/28/23 if that occurs.
19-Sep-2023 - Put Ojjaara into service on 18-Sep-2023.
Review Comments
Looking for approval on 5/20/23.
Oncology drug - needs specialty handling.
Status Notes
Requested audio file for pronunciation of Momelotinib from Carol on 4/2/2023 at about 12:15pm.
Received audio file from Carol on 4/6/2023 at 1:02pm.
Created CW ticket 714565 on 4/8/2923 at 5:37am and sent that and the audio files to Eric directly at 5:41am.
4.14 - Added to grammar file. Waiting on recordings due back later today. Ready for testing on Monday.
1-May-2023 - Eric - Product has been added to the grammar file and is waiting on FDA approval. Product routing and characteristics are already in Production but are not accessible until grammar file is in place.
16-June-2023 - Carol - Ojjaara extended until 9/16/23 for FDA approval.